SC 13G: CONDUIT PHARMACEUTICALS INC.
Ticker: CDTTW · Form: SC 13G · Filed: Oct 11, 2024 · CIK: 1896212
| Field | Detail |
|---|---|
| Company | Conduit Pharmaceuticals Inc. (CDTTW) |
| Form Type | SC 13G |
| Filed Date | Oct 11, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by CONDUIT PHARMACEUTICALS INC..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G filing submitted by Conduit Pharmaceuticals Inc. (ticker: CDTTW) to the SEC on Oct 11, 2024.
What is the risk level of this SC 13G filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (ame of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti).
How long is this filing?
Conduit Pharmaceuticals Inc.'s SC 13G filing is 4 pages with approximately 1,228 words. Estimated reading time is 5 minutes.
Where can I view the full SC 13G filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,228 words · 5 min read · ~4 pages · Grade level 8.4 · Accepted 2024-10-11 06:01:23
Key Financial Figures
- $0.0001 — ame of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti
Filing Documents
- tm2425992d1_sc13g.htm (SC 13G) — 52KB
- 0001104659-24-107836.txt ( ) — 54KB
Signatures
Signatures After reasonable inquiry and to the best of the knowledge and belief of each of the undersigned, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. October 11, 2024 AstraZeneca PLC /s/ Adrian Kemp Signature Adrian Kemp, Company Secretary Name/Title AstraZeneca AB /s/ Lars-Johan Cederbrant Signature Lars-Johan Cederbrant, Director and CFO Name/Title Attention : Intentional misstatements or omissions of fact constitute federal criminal violations ( see 18 U.S.C. 1001). Page 6 of 6